Arrowstreet Capital, Limited Partnership Astrazeneca PLC Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 332,341 shares of AZN stock, worth $22.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

332,341

Previous 261,335 27.17%

Holding current value

$22.1 Million

Previous $20.4 Million 27.05%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $5.44 Million - $6.22 Million	71,006 Added 27.17%	332,341 $25.9 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $17.5 Million - $21.1 Million	261,335 New	261,335 $20.4 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $82.8 Million - $92.7 Million	-1,338,172 Reduced 94.96%	70,961 $4.78 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $115 Million - $127 Million	-1,775,235 Reduced 55.75%	1,409,133 $95.4 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $117 Million - $127 Million	-1,671,832 Reduced 34.43%	3,184,368 $228 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $59.2 Million - $67.1 Million	937,657 Added 23.93%	4,856,200 $337 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $203 Million - $264 Million	3,746,688 Added 2180.14%	3,918,543 $266 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $182 Million - $466 Million	-3,429,356 Reduced 95.23%	171,855 $9.43 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $29.2 Million - $35 Million	-492,134 Reduced 12.02%	3,601,211 $238 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $183 Million - $221 Million	3,286,137 Added 407.1%	4,093,345 $272 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $43.6 Million - $51.5 Million	807,208 New	807,208 $47 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $17.6 Million - $19.2 Million	-316,615 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $140 Million - $174 Million	-2,883,038 Reduced 90.1%	316,615 $19 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $217 Million - $251 Million	-4,608,141 Reduced 59.02%	3,199,653 $159 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $16.4 Million - $19.6 Million	338,138 Added 4.53%	7,807,794 $390 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $33.5 Million - $38.6 Million	-632,110 Reduced 7.8%	7,469,656 $409 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $115 Million - $147 Million	2,661,922 Added 48.93%	8,101,766 $429 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $121 Million - $164 Million	-3,188,796 Reduced 36.96%	5,439,844 $243 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $1.73 Million - $2.05 Million	40,719 Added 0.47%	8,628,640 $430 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $31.2 Million - $35.4 Million	-777,638 Reduced 8.3%	8,587,921 $383 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $115 Million - $129 Million	-3,093,809 Reduced 24.83%	9,365,559 $387 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $26.7 Million - $32.4 Million	752,118 Added 6.42%	12,459,368 $504 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $223 Million - $251 Million	6,043,271 Added 106.7%	11,707,250 $445 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $144 Million - $165 Million	4,144,146 Added 272.67%	5,663,979 $224 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $50.2 Million - $53.8 Million	1,452,024 Added 2141.34%	1,519,833 $53.4 Million
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $22 Million - $24.4 Million	-665,773 Reduced 90.76%	67,809 $2.37 Million
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $23.5 Million - $25.5 Million	733,582	733,582 $25.5 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Astrazeneca PLC Transaction History